Search Within

Ryan Schofield

Formats
  1. Journal Article (19)
  2. Meeting Abstract (10)
Groups
  1. Department of Pathology and Laboratory Medicine (28)
  2. Bone Marrow Transplant (16)
  3. CTCR Scholars (16)
  4. Center for Hematologic Malignancies (16)
  5. Department of Medicine (16)
  6. Hematologic Malignancies, Division of (16)

More Groups

People
  1. Dean Carlow (28)
  2. Gunjan Shah (16)
  3. Andrew Lin (12)
  4. Michael Scordo (12)
  5. Sergio Giralt (10)
  6. Heather Landau (9)

More People

Years
  1. 2024 (6)
  2. 2022 (4)
  3. 2020 (3)
  4. 2019 (2)
  5. 2018 (4)
  6. 2017 (4)

More Years

Publications
  1. Methods in Molecular Biology (9)
  2. Biology of Blood and Marrow Transplantation (4)
  3. Blood (3)
  4. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences (3)
  5. BMC Cancer (1)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. Humana Press Inc (9)
  2. Elsevier Inc. (5)
  3. American Society of Hematology (3)
  4. Elsevier Science BV (2)
  5. Nature Publishing Group (2)
  6. Adis International Ltd (1)

More Publishers

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacokinetics of melphalan in lymphoma patients undergoing beam and autologous hematopoietic stem cell transplant
    Meeting Abstract

    Dahi, P.; Lin, A.; Flynn, J.; Uruburo, C.; Mcgeary, I.; Schofield, R.; Bhatt, V.; Derespiris, L.; Figgins, B.; Griffin, M.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Effect of melphalan exposure in patients with lymphoma undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Lin, A.; Dahi, P. B.; Flynn, J.; Uruburo, C.; Mcgeary, I.; Schofield, R.; Bhatt, V.; DeRespiris, L.; Figgins, B.; Griffin, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Successful personalization of propylene glycol free melphalan (PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT) using pharmacokinetic (PK)-directed dosing
    Meeting Abstract

    Shah, G. L.; Lin, A.; Kamrowski, A.; Carino, C. A.; Schofield, R.; Devlin, S. M.; Bhatt, V.; Proli, A. J.; Chung, D. J.; Dahi, P. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry
    Journal Article

    Schofield, R. C.; Landau, H. J.; Giralt, S. A.; Shah, G. L.; Scordo, M.; Lin, A.; Zanutto, E.; Ramanathan, L. V.; Pessin, M. S.; Carlow, D. C.
    Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences (2019)

    Fulltext@MSK | Save
  • Dysgeusia is associated with higher melphalan pharmacokinetic levels and results in poorer caloric intake and worse symptom burden after autologous stem cell transplantation for multiple myeloma
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Preston, E. V.; Rodriguez, N.; Lin, A.; Maloy, M.; Mastrogiacomo, B.; Carlow, D.; Schofield, R.; Knezevic, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Data to support a simultaneous testosterone and estradiol assay in serum by LC-MS/MS
    Journal Article

    Schofield, R. C.; Ramanathan, L. V.; Pessin, M. S.; Carlow, D. C.
    Data in Brief (2018)

    Fulltext@MSK | Save
  • Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S.; Devlin, S. M.; Castro-Malaspina, H.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
    Blood (2017)

    Fulltext@MSK | Save